Flagship VentureLabs IV LLC 13D/13G Filings for Seres Therapeutics, Inc. (MCRB)

Flagship VentureLabs IV LLC 13D and 13G filings for Seres Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-07-07
5:00 pm
Purchase		 2022-07-05 13D Seres Therapeutics, Inc.
MCRB		 Flagship VentureLabs IV LLC 1,174,653
18.900%		 422,154increase
(+56.10%)		 Filing
2020-11-25
4:30 pm
Sale		 2020-11-23 13D Seres Therapeutics, Inc.
MCRB		 Flagship VentureLabs IV LLC 752,500
16.500%		 -329,846decrease
(-30.48%)		 Filing